Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Solid Tumor × spartalizumab × Clear all

Sponsor

Conditions

Melanoma 7 Pancreatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 4 Head and Neck Neoplasms 3 Sarcoma 2 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Liver Neoplasms 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Metastatic Pancreatic Ductal Adenocarcinoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Kidney Neoplasms 1 Kidney Diseases 1

Interventions

pertuzumab 2 durvalumab 2 Paclitaxel 2 Nivolumab 2 Docetaxel 2 Capecitabine 2 ulocuplumab 1 tremelimumab 1 tazarotene 1 talazoparib 1 romiplostim 1 pexidartinib 1 pembrolizumab 1 pamiparib 1 magrolimab 1 entrectinib 1 cobimetinib 1 atezolizumab 1 Sunitinib 1 Rifampin 1 Radiosurgery 1 Midazolam 1 LY3022855 1 LY2510924 1 Itraconazole 1 Irinotecan 1 Ipilimumab 1 Dextromethorphan 1 Carboplatin 1 CH5183284 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡